Clinical Trial

Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity

Study acronym: STROKEPOC
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This is a randomized parallel group clinical trial which will be conducted in three countries (Spain, Canada and Belgium) comparing Botulinum Toxin type A (BTX-A) and Dry Needling (DN) effectiveness for post-stroke spasticity in participants who had a first stroke in the previous 12 months and have plantar flexor spasticity. Participants will be randomly allocated to receive either one session of BTX-A or 12 weekly sessions of DN. Blinded evaluators will assess the effects before, during, and after treatment, and at a 4-week follow-up.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-28; most recent amendment 2026-04-28.
Status change: Not Yet Recruiting → Recruiting 2025-02-17
Trial Details
NCT Number NCT06296082
Lead Sponsor Universiteit Antwerpen
Collaborators: Instituto de Investigación Sanitaria Aragón, McGill University, Instituto de Salud Carlos III, Fonds de la Recherche en Santé du Québec, Research Foundation Flanders
Conditions Stroke
Enrollment 90 participants
Start Date 2024-09-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-03-29 (estimated)
Updated on ClinicalTrials.gov 2026-05-04